6th Oct 2023 The TOPAZ-1 study: a plain language summary describing durvalumab and chemotherapy for advanced biliary tract cancer
22nd Sep 2023 A plain language summary of the HIMALAYA study which looked at tremelimumab and durvalumab for unresectable hepatocellular carcinoma